Launch of PHC v.1: Drugs and Diagnostics Together

The merger of Genentech and Roche brought together the premier developer of targeted therapeutics and clinical diagnostics. This unique partnership led to the development of the first Roche-wide PHC efforts or “Development of Drugs and Diagnostics Together”. To help realize the power of this partnership we developed goals for each molecule team to have a formal biomarker/diagnostic plan and to partner early with their Roche DIA colleagues to ensure both molecule and assay plan were aligned.